8% Off
Tridopa100 mg+25
ACI Limited
৳92.29
Add to cart
Generic medicine
Levodopa + Carbidopa + Entacapone: Brands, Price & Uses in Bangladesh
Levodopa + Carbidopa + Entacapone is a fixed-dose triple combination indicated for the treatment of idiopathic Parkinson's disease in patients who experience signs and symptoms of end-of-dose…
About Levodopa + Carbidopa + Entacapone
Indications of Levodopa + Carbidopa + Entacapone
Levodopa + Carbidopa + Entacapone is a fixed-dose triple combination indicated for the treatment of idiopathic Parkinson's disease in patients who experience signs and symptoms of end-of-dose "wearing-off" motor fluctuations that are not adequately controlled with immediate-release levodopa/carbidopa alone.
Evidence-based indication summary
- FDA-approved/established use: substitution therapy for patients already stabilized on immediate-release levodopa and carbidopa (or another peripheral decarboxylase inhibitor) plus separate entacapone, or for patients on levodopa/carbidopa experiencing predictable end-of-dose wearing-off, in whom addition of a COMT inhibitor is appropriate.
- Not indicated for initial (de novo) treatment of Parkinson's disease; patients should first be titrated on individual levodopa/carbidopa (and, if needed, entacapone) before conversion to a fixed combination product.
- Adjunct therapy requirement: Levodopa + Carbidopa + Entacapone is only used as an adjunct to, and never as a substitute for, an individualized levodopa/carbidopa regimen — it does not work as monotherapy because it contains no additional levodopa beyond what is already balanced with carbidopa and entacapone in each tablet strength.
Dosage & Administration of Levodopa + Carbidopa + Entacapone
General dosing principle
The dose of Levodopa + Carbidopa + Entacapone must be individualized by titrating the levodopa component to the lowest dose that provides satisfactory symptom control, based on the patient's prior levodopa/carbidopa requirement. Patients are typically converted to the tablet strength that matches their current levodopa dose per administration, taken with each levodopa/carbidopa dose.
| Indication | Adult dose | Notes |
|---|---|---|
| Parkinson's disease with end-of-dose wearing-off | One tablet (matching the patient's current levodopa dose) with each scheduled levodopa/carbidopa administration, up to a maximum of 8 tablets/day (entacapone 1600 mg/day) | Entacapone component should not exceed 200 mg per dose or 1600 mg/day (8 doses); interval between doses is individualized based on response |
| Conversion from separate levodopa/carbidopa + entacapone | Matched tablet strength for the equivalent levodopa dose, given at the same dosing interval | Physician-supervised switch only |
Renal impairment
No dose adjustment is established as routinely necessary for renal impairment, but caution is advised and clinical response should be monitored, as levodopa and carbidopa are partly renally eliminated.
Hepatic impairment
Entacapone is extensively hepatically metabolized; Levodopa + Carbidopa + Entacapone should be used with caution in patients with hepatic impairment, and dose reduction or closer monitoring may be needed. Not formally studied in severe hepatic impairment.
Missed dose
Take the missed dose as soon as remembered unless it is close to the next scheduled dose; do not double the dose. Never stop Levodopa + Carbidopa + Entacapone abruptly (see Precautions and Warnings).
Side Effects of Levodopa + Carbidopa + Entacapone
Adverse effects reported with Levodopa + Carbidopa + Entacapone include both dopaminergic effects (shared with levodopa/carbidopa) and effects specific to the entacapone component.
- Very common/common: dyskinesia, nausea, diarrhea, urine discoloration (reddish-brown; harmless, caused by entacapone metabolites), orthostatic hypotension/dizziness, hyperhidrosis (excess sweating), abdominal pain.
- Neuropsychiatric: hallucinations, confusion, vivid dreams, and other psychotic-like symptoms, more common in elderly patients.
- Impulse control disorders: pathological gambling, hypersexuality, compulsive shopping/eating, and other compulsive behaviors have been reported with dopaminergic therapy including Levodopa + Carbidopa + Entacapone.
- Less common but important: somnolence and sudden onset of sleep, syncope, worsening of pre-existing dyskinesia.
Contraindications of Levodopa + Carbidopa + Entacapone
Levodopa + Carbidopa + Entacapone is contraindicated in:
- Known hypersensitivity to levodopa, carbidopa, entacapone, or any component of the formulation.
- Patients receiving nonselective monoamine oxidase (MAO) inhibitors, or within 14 days of stopping one, because of the risk of hypertensive crisis.
- Narrow-angle glaucoma (uncontrolled angle-closure glaucoma), because of the risk of increased intraocular pressure.
Frequently Asked Questions about Levodopa + Carbidopa + Entacapone
What is Levodopa + Carbidopa + Entacapone used for?
Levodopa + Carbidopa + Entacapone is used in Parkinson's disease to treat end-of-dose "wearing-off" motor fluctuations in patients who are already taking levodopa/carbidopa but continue to experience a return of symptoms before their next dose is due. It is not used to start Parkinson's disease treatment from scratch.
Can I stop taking Levodopa + Carbidopa + Entacapone suddenly if I feel better?
No. Levodopa + Carbidopa + Entacapone must never be stopped or reduced abruptly. Sudden discontinuation can cause a serious reaction with high fever, muscle rigidity, and confusion, similar to neuroleptic malignant syndrome, and can also cause muscle breakdown (rhabdomyolysis). Always talk to your physician before changing or stopping your dose.
Why does my urine turn a reddish-brown color while taking Levodopa + Carbidopa + Entacapone?
Reddish-brown urine discoloration is a known, harmless effect of the entacapone component of Levodopa + Carbidopa + Entacapone. It does not indicate kidney damage or bleeding, but if you are concerned or notice other symptoms, discuss it with your physician.
Can Levodopa + Carbidopa + Entacapone be taken with iron tablets or a high-protein meal?
Iron supplements and high-protein meals can both reduce the absorption and effect of the levodopa in Levodopa + Carbidopa + Entacapone. It is best to separate the timing of iron tablets from your Levodopa + Carbidopa + Entacapone dose and to keep your protein intake consistent and spaced from your doses, as advised by your physician or dietitian.
Is Levodopa + Carbidopa + Entacapone safe during pregnancy or breastfeeding?
Data are limited. Levodopa + Carbidopa + Entacapone should be used in pregnancy only if the potential benefit clearly outweighs the potential risk to the baby, and only under close medical supervision. It may also reduce breast milk production and its passage into breast milk is not well characterized, so discuss breastfeeding plans with your physician before use.
What should I do if I notice new gambling urges, hypersexuality, or compulsive behavior while on Levodopa + Carbidopa + Entacapone?
These can be impulse control disorders associated with dopaminergic medicines including Levodopa + Carbidopa + Entacapone. Report any such changes to your physician promptly, as dose adjustment or a change in therapy may be needed.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.